skip to Main Content

Treatment Action Group (TAG) recognizes the importance of intentionally engaging the community broadly in our advocacy efforts, and we believe that the community should always be at the forefront of advocacy and research. Meaningful community engagement builds trust and fosters open dialogue between the community, researchers, and policymakers. Without community involvement, our scientific and advocacy efforts will be in vain. Among TAG’s extensive community efforts, TAG facilitates robust community engagement in domestic HIV research through our partnerships with the Black AIDS Institute (BAI)  and the Southern AIDS Coalition (SAC), with support from Fred Hutch. These partnerships have allowed us to assist in developing future HIV prevention advocates through We The People Research Cohort, which addresses the lack of minority representation within research protocol development and participation and meets the need for the development of HIV advocacy training by centering the needs of Black and Brown people.

We understand that the U.S. communities most impacted by HIV are geographically located in the Southern region of the United States. Our goal is to provide factual and accessible information to the community through the resources developed for the We The People Research Cohort.

November 11, 2021
Update on HIV Vaccine Research
Publication
Developing an HIV vaccine is a difficult scientific challenge, but remains a critical priority. This handout provides an update on HIV vaccine research and a summary of results from the efficacy trials that have been conducted to date, and it was developed in collaboration with the Black AIDS Institute, HIV…

October 26, 2021
HIV Research Advocacy Fact Sheet
Publication
HIV advocacy laid the foundation for much of the work we do today. This handout was developed in collaboration with the Black AIDS Institute, HIV Vaccine Trials Network, and Southern AIDS Coalition. The handout provides a summary of the history of HIV research advocacy and updates on new HIV advocacy…

October 26, 2021
New HIV Prevention Research Fact Sheet
Publication
HIV prevention research continues to rapidly evolve. The availability of pre-exposure prophylaxis (PrEP) has necessitated the development of new approaches to testing the efficacy of additional biomedical HIV prevention options. This handout was developed in collaboration with the Black AIDS Institute, HIV Vaccine Trials Network, and Southern AIDS Coalition. The…

October 26, 2021
Broadly Neutralizing Antibodies for HIV Prevention Fact Sheet
Publication
HIV-specific broadly neutralizing antibodies (bNAbs) could have a role in treating, preventing, or even curing HIV. Some HIV-specific bNAbs are already being tested in clinical trials, both for prevention and treatment. This handout was developed in collaboration with the Black AIDS Institute, HIV Vaccine Trials Network, and Southern AIDS Coalition.…

October 26, 2021
What’s on the Horizon for Long-Acting Pre-Exposure Prophylaxis (PrEP)? Fact Sheet
Publication
Long-acting pre-exposure prophylaxis (PrEP) will be a groundbreaking HIV prevention tool. The approach provides an option to receive intermittent doses of PrEP instead of taking daily pills. This handout provides an update on the development of long-acting PrEP and future prospects for the approach. The handout was developed in collaboration…

October 26, 2021
HIV Science Fact Sheet
Publication
HIV science can be difficult to understand. This handout explains some of the unique scientific challenges presented by HIV. The handout was developed in collaboration with the Black AIDS Institute, HIV Vaccine Trials Network, and Southern AIDS Coalition.

October 19, 2021
TAG and COVID-19 Prevention Network Fact Sheets
Publication
These three fact sheets were developed by TAG in partnership with the COVID-19 Prevention Network (CoVPN) and the Black AIDS Institute (BAI), and they aim to foster community understanding of COVID-19 vaccine research and development, as well as highlight community perspectives on the topic.

September 14, 2021
The Future of HIV Biomedical Prevention Research
Webinar / Presentation
Abraham Johnson, TAG’s Community Engagement Officer, presented this webinar with Carl Dieffenbach, Director of the Division of AIDS at the National Institute for Allergy and Infectious Diseases (NIAID), where he provided an update on the future of biomedical HIV prevention research.

March 5, 2021
How Lessons Learned from the HIV Epidemic Can Inform Efforts to Address the COVID-19 Pandemic Through a Racial Equity Lens
Webinar / Presentation
Join us on March 15, 2021 at 4:00 p.m. EST for this free webinar, which will discuss a variety of issues concerning disenfranchised communities being disproportionately affected by COVID-19.

January 26, 2021
TAG/COVID-19 Prevention Network: HIV, COVID-19 Outcomes and Implications for COVID-19 Vaccines
Webinar / Presentation
Join TAG and COVID-19 Prevention Network (CoVPN) On Tuesday February 2nd at 4pm ET / 1pm PT, at a webinar for community advocates on COVID-19 outcomes in people living with HIV and implications for COVID-19 vaccines.

March 6, 2020
The Future of Biomedical HIV Prevention Trials: Researcher Viewpoints and Community Survey
Publication
This report aims to make more accessible to community advocates discussions around ethical conduct of biomedical prevention trials in the era of PrEP. In early 2019, TAG, along with Black AIDS Institute and the HIV Vaccine Trials Network developed an online survey, asking for diverse community input on existing and…

Back To Top